Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01078350 · ClinicalTrials.gov registry record
Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 93
- Enrollment target
NCT01078350: Completed study, sponsored by Stanford University.
NCT01078350 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 93 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01078350 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 93 participants
- Enrollment target
Study Summary
This study is designed to collect tissue samples that may aid in the treatment and learning about various oncology diagnosis.
Interventions
- PROCEDURE phlebotomy
- PROCEDURE tumor tissue aspiration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2004-05 |
| Est. Completion | 2015-12-04 |
What the finished NCT01078350 record still lists
NCT01078350 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 93 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which phlebotomy is the first listed.
NCT01078350 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01078350 about?
NCT01078350 is a clinical study titled "Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy". This study is designed to collect tissue samples that may aid in the treatment and learning about various oncology diagnosis.
What is the current status of trial NCT01078350?
This trial is currently completed. The enrollment target is 93 participants. The study started on 2004-05. Estimated completion is 2015-12-04.
What interventions are being tested in trial NCT01078350?
The interventions under investigation include: phlebotomy (PROCEDURE), tumor tissue aspiration (PROCEDURE).
Who is sponsoring clinical trial NCT01078350?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02203526 · 93 participants · Phase 1
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
- NCT03089554 · 93 participants · Phase 2
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
- NCT05000021 · 93 participants · NA
Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes
- NCT05489887 · 93 participants · Phase 2
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia